![]() ![]() Method of Participation and Request for Creditįees for participating and receiving CME credit for this activity are as posted on The ObG Project website. Planners and Managers: The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose. Gross, MD, receives consulting fees from Cradle Genomics, and has financial interest in The ObG Project, Inc. ![]() The OBG Project planners and others have nothing to disclose.įaculty: Susan J. The PIM planners and others have nothing to disclose. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. ![]() All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. President and CEO, The ObG Project Disclosure of Conflicts of Interest Apply the ACOG guidance when managing women at risk of VTE due to inherited thrombophiliasĮstimated time to complete activity: 0.5 hours Faculty: Discuss the inherited thrombophilias and differentiate between low and high risk thrombophiliasĢ. This activity is intended for healthcare providers delivering care to women and their families.Īfter completing this activity, the participant should be better able to:ġ. ![]()
0 Comments
Leave a Reply. |